CRBP (Corbus Pharmaceuticals) Net earnings per share growth this year

CRBP (Corbus Pharmaceuticals, Inc.) - company brandmark

Expansion risks into precision oncology and fibrosis treatment drive volatility, where the YoY earnings per share trend visualizes the reaction to market challenges. The -1.90 level reflects the current magnitude of this metric. Stability is provided by AI molecule modeling and synthesis automation, as well as the retention of top clinical phase experts through an options system for Corbus Pharmaceuticals (CRBP).

Earnings per share growth in current year: Corbus Pharmaceuticals Holdings, Inc. (CRBP) for 07/04/2022 - 11/17/2026

Financial and market metric breakdowns for corbuspharma.com (CRBP)

Summary company analysis:CRBP Corbus Pharmaceuticals
Signature product of Corbus Pharmaceuticals

Corbus Pharmaceuticals focuses on developing innovative therapeutics for rare forms of cancer, leveraging the potential of its clinical pipeline. The earnings per share trend, captured by the value -1.90, reflects the rate of change in net income per share year-over-year, allowing investors to assess capitalization efficiency via the YoY earnings per share growth percentage.

Key competitors

Earnings per share growth this year INCY|Earnings per share growth in current year Hutchison MediPharma|Net earnings per share growth this year nuvationbio.com (NUVB)|Earnings per share growth in current year Day One Biopharmaceuticals Inc (DAWN)|MNPR - Earnings per share growth rate in current year|Earnings per share growth in current year Inhibrx Biosciences Inc INBX|I-Mab - Earnings per share growth in current year|FENC - Earnings per share growth in current year|Earnings per share growth rate in current year herontx.com|NVCT: Earnings growth in current year|Net earnings per share change in current year Coherus CHRS|Net earnings per share growth this year CRDF|Earnings per share growth rate in current year BeyondSpring Inc. BYSI|Net earnings per share growth this year BCAB (BioAtla Inc)|LIXT (Lixte Biotechnology Holdings, Inc.) - Earnings per share increase in current year|Citius Pharmaceuticals, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year CLRB (Cellectar Biosciences, Inc.)|BioLineRx Corp - Earnings growth in current year|Earnings per share increase in current year CANF (Can-Fite BioPharma, Ltd.)|APRE: Earnings growth in current year|Earnings per share growth rate in current year Kazia (KZIA)|Earnings per share growth in current year silexion.com|NCNA: Earnings per share increase in current year|Earnings growth in current year CMRX|Earnings growth in current year Cyclacel, Inc. (CYCC)|Earnings per share growth in current year G1 Therapeutics Inc. GTHX|KRON (Kronos Bio) - Earnings per share trend in current year|KTRA: Net earnings per share growth this year|Earnings per share growth rate in current year Oncternal Therapeutics Inc|Portage Biotech (PRTG) - Earnings per share growth in current year